Skip to main content
. Author manuscript; available in PMC: 2016 Nov 3.
Published in final edited form as: Crit Care Med. 2015 Mar;43(3):603–612. doi: 10.1097/CCM.0000000000000747

Table 2.

Respondents’ Acceptance of Main Trial Components (n=85)

Strongly agree Strongly disagree Don’t know/refuse
1 2 3 4 5
It is important to do research to find out whether new treatments can improve care for patients with TBI. 68
(80%)
13
(15%)
0
(0%)
2
(2%)
0
(0%)
2
(2%)

I am glad that I/my family member was included in this research study. (Before explicit EFIC discussion) 56
(66%)
15
(18%)
8
(9%)
2
(2%)
1
(1%)
3
(4%)

I think it was ok for researchers to include me/my family member in the PROTECT III research study without asking for permission first. (After EFIC discussion) 54
(64%)
12
(14%)
11
(13%)
2
(2%)
2
(2%)
4
(5%)

I think that it was ok for researchers to include people in the PROTECT research study without asking them for permission first. (After EFIC discussion) 44
(52%)
17
(20%)
14
(16%)
6
(7%)
3
(4%)
1
(1%)

I think that it was acceptable for researchers to give half of the patients in the PROTECT study placebo and half of the patients Progesterone. 55
(65%)
13
(15%)
9
(11%)
2
(2%)
1
(1%)
5
(6%)

I think that it was acceptable for researchers to assign treatments at random in this study. 63
(74%)
15
(18%)
5
(6%)
0
(0%)
1
(1%)
1
(1%)